Rheaply
Resource exchange platform helping world-leading organizations better visualize and utilize their materials & resources.
Est 2015|Valuation $82M|Raised $34.3M
Published Jun 25, 2026
Several universities publish program pages that describe operational use of Rheaply instances and applicable policies. For example, the University of Chicago describes an internal reuse marketplace and notes policy constraints relevant to laboratory exchanges.
Source:
Discussion on mainstream technology forums is limited. Examples include a historical Reddit AMA by Rheaply leadership and brief user comments in supply-chain forums. These sources provide limited operational insights and are not a substitute for formal customer references.
Sources:
What is reported:
Critical evaluation:
Source:
Get a comprehensive analysis of Rheaply including market position, competitive landscape, adoption trends, and peer benchmarks.
Download full report →Sources:
This limited public footprint complicates validation of support quality and usability through third-party review platforms.
Sources:
Sources:
Sources:
Source:
Sources:
Sources:
Where other vendors differ
Source:
Public, third-party customer review volume for Rheaply is limited in accessible review platforms:
Sources:
Rheaply’s site includes quotes from named individuals and organizations describing operational outcomes; these are curated by the vendor and should be reviewed alongside independent references for procurement decisions. Examples referenced in vendor materials include an Allina Health quote describing operational outcomes for rehoming items and a Barnard College quote emphasizing increased asset visibility and access.
Source:
There is very limited public, product-specific negative feedback on mainstream review platforms. Sources that can provide additional signals include employee reviews (e.g., Glassdoor) which may indicate internal execution risk, and lower-signal aggregator sites with limited verification.
Recommendations: prospective buyers should obtain reference calls (ideally from multi-site customers), run a pilot, and negotiate contractual service-level agreements and support commitments.
Sources:
Summary: The public record contains primarily vendor and partner–published case studies and limited independent buyer feedback. Independent validation through references and pilots is advised.
What is reported:
Critical evaluation:
Source:
What is reported:
Critical evaluation:
Sources:
What is reported:
Critical evaluation:
Source:
Rheaply is a B2B SaaS platform focused on enabling physical-asset reuse operations inside organizations and, in some programs, across networks. Its functional components include:
Rheaply also operates and supports public/local reuse marketplaces (for example, city or regional reuse programs), where verified organizations can donate, buy, or sell surplus workplace items and certain building materials.
Primary stated benefits: reduced over-purchasing, shorter project lead times, recovered value from idle assets, and support for ESG and waste diversion reporting through asset lifecycle management and reuse.
Sources:
Rheaply is positioned for:
The company positions the product as infrastructure for circular operations rather than as a traditional IT asset management solution.
Sources: